RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: A 10-year follow-up

Leukemia

Volumn 12, Issue 6, 1998, Pages 887-892

  Padua, R A ^a,b   Guinn, B A ^a,c   Al Sabah, A I ^a   Smith, M ^a,d   Taylor, C ^a,e   Pettersson, T ^a,f   Ridge, S ^a,g   Carter, G ^a,h   White, D ⁱ   Oscier, D ^j   Chevret, S ^b   West, R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SAINT LOUIS HOSPITAL   (France)

^c Medical Sciences Building ^*  (Canada)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

^e BRISTOL ROYAL INFIRMARY   (United Kingdom)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

^h MERCK KGAA   (Germany)

ⁱ UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^j ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

more..

Author keywords

Clinical outcome; FMS p53; MDS; RAS

Indexed keywords

PROTEIN P53;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL TRANSFORMATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CODON; FEMALE; GENE MUTATION; GENETIC STABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; ONCOGENE RAS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 17344371122     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401044     Document Type: Article

References (16)

1. Koeffler HP. Myelodysplastic syndromes (preleukemia). Semin Hematol 1986; 23: 284-299.
2. Raza A, Gezer S, Mundle S, Gao X-Z, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chancy C, Showel J, Gregory S, Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268-276.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Grainick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Hacmatol 1982; 51: 189-199.
4. Bennett JM. Classification of the myelodyplastic syndrome. Clin Hematol 1986; 15: 909-923.
5. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59: 425-433.
6. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF. Two regression models and a scoring system for predicting survivals and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395-408.
7. Morel P, Hebbar M, Lai J-L, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 9: 1315-1323.
8. Greenberg P, Cox C, Le Beau M, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennnet J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
9. Heim S, Mitelman F. Chromosome abnormalities in myelodysplastic syndromes. Clin Hematol 1986; 15: 1003-1007.
10. Musilova J, Michelova K. Chromosome study of 85 patients with myelodysplastic syndrome. Cancer Genet Cytogenet 1988; 33: 39-42.
11. Guinn BA, Smith M, Padua RA, Burnett AK, Mills KI. Changing p53 mutations with the evolution of chronic myeloid leukemia from the chronic phase to blast crisis. Leukemia Res 1995; 19: 519-525.
12. Foti A, Ahuja HC, Allen SL, Koduru P, Schuster MW, Schulman P, Bar-Eli M, Cline MJ. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia in blast crisis. Blood 1991; 77: 2441-2444.
13. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1982.
14. ISCN (1985). Harnden DC, Klinger HP (ed.) An international system for cytogenetic nomenclature. Published in collaboration with Cytogenet Cell Genet. Karger: Basel, 1985.
15. Padua RA, Carter G, Hughes D, Gow J, Farr C, Oscier D, McCormick F, Jacobs A. RAS mutations in myelodysplasia detected by oligonucleotide hybridization and transformation. Leukemia 1988; 2: 503-510.
16. Saiki RK, Bugawanr TC, Horn GT, Mullis KB, Erlich HA. Analysis of enzymically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163-166.